Proventa Biology Strategy Meeting – San Francisco
The Proventa Biology Strategy Meeting in San Francisco on May 9th, 2022, is a patient-centric pharmaceutical industry event featuring personalized agendas with roundtable discussions, one-to-one strategic meetings, and networking opportunities designed to facilitate collaboration among industry leaders for the discovery, development, and commercialization of life-saving therapies.
Introduction
Join us for the Proventa Biology Strategy Meeting in San Francisco, CA.
Proventa provides a platform for creating life-saving therapies and aims to facilitate the creation of a completely patient-centric pharmaceutical industry. The event encourages key leaders and their companies to put the patient at the center of every innovation, sharing valuable insights and strategies to assist in the discovery, development, and commercialization of life-saving therapies.
Roundtable Discussions
These interactive and informal discussion groups are the hallmark of the meeting. The brightest minds in the industry are brought together in 60-minute sessions that enable participants from all over the world to share ideas, challenges, and lessons learned.
Personalized Agenda
Each delegate receives a personalized agenda with the roundtable discussions that they choose. You only attend sessions and meetings that fit your challenges and interests, ensuring your time spent on the online platform is focused and well-utilized.
One-to-one Meetings
This is the most effective and time-efficient way to assess potential partners at a strategic level. Identify key solution providers that can take your business to the next level, and private meetings will be arranged so you can connect.
Strategic Networking
Strategic networking opportunities form a key benefit of the meeting. The new online format is designed for building and strengthening alliances to make lasting connections that benefit you.
Event Details
- Date: May 9th, 2022
- Location: The Westin St. Francis, 335 Powell Street, San Francisco, CA 94102
- Time:
- 5:30pm – 2:40am CEST
- 4:30pm – 1:40am BST
- 11:30am – 8:40pm EDT
- 8:30am – 5:40pm PDT
Related
Proventa | Bioinformatics Strategy Meeting - Boston
The Proventa Bioinformatics Strategy Meeting in Cambridge, MA on May 23, 2022, is a patient-centric event featuring personalized agendas with interactive roundtable discussions, one-to-one strategic meetings, and networking opportunities designed to unite industry leaders in advancing the discovery, development, and commercialization of life-saving therapies.
Proventa | Biology Strategy Meeting - Boston
The Proventa Biology Strategy Meeting in Cambridge, MA on May 24th, 2022 is a patient-centric pharmaceutical industry event featuring personalized agendas with interactive roundtable discussions, one-to-one strategic meetings, and networking opportunities designed to facilitate collaboration among industry leaders for the discovery, development, and commercialization of life-saving therapies.
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.
Agility, Flexibility, and Collaboration: The Three Principles That Redefined Post-Pandemic R&D
The COVID-19 pandemic permanently transformed R&D by establishing agility through AI and faster learning cycles, flexibility via adaptive trial methods, and enhanced collaboration through open data and public-private partnerships, setting a new standard for rapid, rigorous, and cooperative scientific innovation in healthcare.
Dotmatics helping scientists make better drugs in less time using AI
Dotmatics executives Kalim Saliba and Steve Tharp explain in a CBS News Boston feature how the company leverages artificial intelligence to transform pharmaceutical drug discovery by providing innovative solutions that accelerate and improve the efficiency of scientific research and development in the life sciences sector.
Don’t Get Distracted By AI, Instead Focus on Intellectual Property
Thomas Swalla, CEO of Dotmatics, argues in Pharmaceutical Executive that while AI accelerates drug development, pharmaceutical companies should prioritize intellectual property and robust data management as the essential foundations for true innovation and effective matching of drug candidates to diseases.